fbpx
Size of letters 1x
Site color
Image
Additionally
Line height
Letter spacing
Font
Embedded items (videos, maps, etc.)
 

A New Register of Medicines Subject to Reimbursement Approved

23/ 01/ 2018
  Within the government reimbursement program Affordable Medicines, based on the results of consideration of applications of manufacturers, which were accepted from January 2nd, 2018 to January 11th, 2018, Order of the Ministry of Health of Ukraine No. 111 as of January 22nd, 2018 approved an updated Register of Medicines Subject to Reimbursement. The Register contains 239 items of medicines for the treatment of cardiovascular diseases, diabetes of type II and bronchial asthma, which is 41 more than in the previous one. Therefore Order of the Ministry of Health of Ukraine No. 856 as of July 26th, 2017 has expired. The updated Register of Medicines Subject to Reimbursement has been approved taking into account the following: On December 27th, 2017 the Government adopted changes to the Affordable Medicines program, supplementing it with two new active substances for the treatment of cardiovascular diseases and diabetes of type 2 - Lozartan and Glibenclamide. Order of the Ministry of Health of Ukraine No. 2 as of January 2nd, 2018 approved a new register of ex-factory prices for medicines.

Within the government reimbursement program “Affordable Medicines”, based on the results of consideration of applications of manufacturers, which were accepted from January 2nd, 2018 to January 11th, 2018, Order of the Ministry of Health of Ukraine No. 111 as of January 22nd, 2018 approved an updated Register of Medicines Subject to Reimbursement.

The Register contains 239 items of medicines for the treatment of cardiovascular diseases, diabetes of type II and bronchial asthma, which is 41 more than in the previous one.

Therefore Order of the Ministry of Health of Ukraine No. 856 as of July 26th, 2017 has expired.

The updated Register of Medicines Subject to Reimbursement has been approved taking into account the following:

On December 27th, 2017 the Government adopted changes to the “Affordable Medicines” program, supplementing it with two new active substances for the treatment of cardiovascular diseases and diabetes of type 2 – Lozartan and Glibenclamide.

Order of the Ministry of Health of Ukraine No. 2 as of January 2nd, 2018 approved a new register of ex-factory prices for medicines.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Start
in the Telegram bot
Read articles. Share in social networks
0 Shares

Spelling error report

The following text will be sent to our editors: